| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 378 | 332 | 361 | 312 | | Cost of Revenue | 126 | 109 | 131 | 109 | | | Gross Profit | 253 | 223 | 230 | 203 | | | Operating Expenses | | Research Development | 1,435 | 1,134 | 1,561 | 959 | | Selling General and Administrative | 975 | 649 | 759 | 622 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,158) | (1,560) | (2,091) | (1,378) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5 | 5 | 24 | 55 | | Earnings Before Interest And Taxes | (2,152) | (1,555) | (2,066) | (1,323) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,152) | (1,555) | (2,066) | (1,323) | | Income Tax Expense |
-
|
-
|
-
| (553) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,152) | (1,555) | (2,066) | (771) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,483 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,152) | (1,555) | (2,066) | 712 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,152) | ($1,555) | ($2,066) | $712 |
|
0.11% Nasdaq 
0.01%
Income Statement
